Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,759
Total Claims
$750K
Drug Cost
634
Beneficiaries
$1,183
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+5%
Cost per patient vs peers
$1,183 vs $1,128 avg
+6%
Brand preference vs peers
8.9% vs 8.4% avg
Brand vs Generic
Brand: 855 claims · $654K
Generic: 8,762 claims · $90K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 97 | $120K |
| Empagliflozin | 55 | $88K |
| Fluticasone/Umeclidin/Vilanter | 32 | $57K |
| Insulin Aspart | 31 | $33K |
| Sitagliptin Phosphate | 29 | $29K |
| Semaglutide | 13 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 38 | $22K |
| Sacubitril/Valsartan | 13 | $19K |
| Insulin Degludec | 28 | $19K |
| Budesonide/Formoterol Fumarate | 21 | $13K |
| Albuterol Sulfate | 154 | $8,650 |
| Fluticasone Propion/Salmeterol | 11 | $8,014 |
| Atorvastatin Calcium | 852 | $6,545 |
| Insulin Degludec | 14 | $5,891 |
| Fluticasone Propion/Salmeterol | 12 | $5,279 |
Prescribing Profile
Patient Profile
72
Avg Age
60%
Female
1.96
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data